Funding Opportunities

Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)

RFA-CA-21-005
Application Receipt Date: February 22, 2021, May 27, 2021, September 29, 2021
Expiration Date: September 30, 2021

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

RFA-CA-21-006
Application Receipt Date: February 22, 2021, September 27, 2021, September 29, 2021
Expiration Date: September 30, 2021

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)

RFA-CA-21-003
Application Receipt Date: February 22, 2021, May 27, 2021, September 29, 2021
Expiration Date: September 30, 2021

Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)

RFA-CA-21-013
Application Receipt Date: June 8, 2021, November 17, 2021
Expiration Date: November 18, 2021

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

RFA-CA-21-014
Application Receipt Date: June 8, 2021, November 17, 2021
Expiration Date: November 18, 2021

Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

RFA-CA-21-015
Application Receipt Date: June 8, 2021, November 17, 2021
Expiration Date: November 18, 2021

Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

RFA-CA-21-016
Application Receipt Date: June 8, 2021, November 17, 2021
Expiration Date: November 18, 2021

Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)

RFA-CA-21-017
Application Receipt Date: June 8, 2021, November 17, 2021
Expiration Date: November 18, 2021